Advanced Search
Users Online: 111
Home
About us
Editorial board
Ahead of print
Current issue
Search
Archives
Submit article
Instructions
Subscribe
Contacts
Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Most cited articles *
Archives
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Cited
Viewed
PDF
REVIEW ARTICLES
Cytokeratin: A review on current concepts
Anoop Kumar, Nithya Jagannathan
January-June 2018, 2(1):6-11
DOI
:10.4103/ijofb.ijofb_3_18
Cytokeratins are proteins which form the intermediate filaments and form the major cytoskeleton of the epithelial cells. It has an enormous role in providing mechanical support to the cell. There are various kinds of cytokeratins each showing varied expression in the epithelium. The cytokeratins can be broadly classified into type I or acidic and type II or basic proteins. The expression of these plays a role in differentiating different types of epithelial cells, thus enabling us to classify tumors. They help in diagnosing different types of tumors and thus have a vital role in diagnostic pathology.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
13
13,741
1,404
Role of periostin in oral squamous cell carcinoma: A systematic review
Sandhya Sundar, Pratibha Ramani, Herald J Sherlin, Gifrina Jayaraj
July-December 2018, 2(2):35-40
DOI
:10.4103/ijofb.ijofb_2_19
Background:
Like any other cancer, tumor microenvironment of oral squamous cell carcinoma (OSCC) is closely connected to every step of its tumorigenesis. Periostin is a unique multifunctional extracellular matrix protein found to be overexpressed in various types of human cancers.
Objective:
The objective of this systematic review is to critically analyze various studies in literature that have reported the expression of emerging novel tumor marker “PERIOSTIN” and to determine its role in OSCC.
Materials and Methods:
Articles on periostin in relation to OSCC were searched in PubMed, EMBASE, MEDLINE, and a thorough Google search was done. Hand search of Journals was also performed. Of nine potentially relevant articles, four were excluded on the grounds of exclusion criteria, and one was excluded being a review article. However, one article was included by internet search and hand search. Of the total of five relevant articles reviewed, the resulting data were collected and tabulated.
Results:
All the five studies reviewed demonstrated an upregulation of periostin in OSCC. Among the five, two studies showed a positive correlation of periostin with the invasive patterns of OSCC. Two of the studies correlated the expression of periostin with angiogenesis and lymphangiogenesis. Four of the five articles reviewed, showed a significant correlation of periostin expression with metastasis of OSCC.
Conclusion:
The inference drawn from this systematic review is that the periostin plays an important role in tumor progression including invasion, angiogenesis, and metastasis of OSCC raising the possibility that it could be used as a molecular target in the therapy of OSCC patients.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
1
6,863
741
Osteosarcoma of jaws: An insight into literature
Fatema Saify, Shilpa Jain
July-December 2018, 2(2):41-46
DOI
:10.4103/ijofb.ijofb_9_18
Osteosarcoma (OS), referred to as osteogenic sarcoma, is the most common primary malignant bone tumor excluding plasma cell tumors. It accounts for approximately 15% of all primary bone tumors confirmed at biopsy. It commonly involves the appendicular skeleton. Like, its counterpart in the long bones, OS affecting the head-and-neck region shows the distinct yet diverse clinical, histologic, and prognostic characteristics. Its diagnosis is a challenge to oral pathologists and is especially important in early stages to improve its prognosis. The data have been taken from the published articles and standard books and are summarized. In this review, in addition to summarizing the current understanding of OS etiology and diagnostic methods, various experimental therapeutics have been described that provides evidence to encourage a potential paradigm shift toward the introduction of immunomodulation, which may offer a more comprehensive approach to battling cancer.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
1
6,667
670
* Source: CrossRef
© International Journal of Orofacial Biology | Published by Wolters Kluwer -
Medknow
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
Online since 19
th
August, 2016